# UFP Technologies, Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/UFP Technologies, Inc). ## Overview UFP Technologies is a U.S.-based contract development and manufacturing company focused on single-use and single-patient medical devices and components. Its products are custom-engineered for medical device manufacturers and are used in areas such as minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. ## Products & services • Custom single-use and single-patient medical devices • Protective drapes for robotic surgery • Infection prevention and surgical disposables • Medical device and implant packaging • Orthopedic soft goods and implant components • Biopharma drug manufacturing components - **Single-use medical devices** (45%) — Custom disposable devices and components used once per patient or procedure. - **Surgical and infection prevention products** (25%) — Products used in minimally invasive surgery, infection control, and procedural protection. - **Orthopedic and implant-related components** (15%) — Soft goods, packaging, and components used in orthopedic and implant applications. - **Wearables and patient care products** (10%) — Comfort, support, and patient-handling products for medical use. - **Biopharma and other specialty applications** (5%) — Specialty manufacturing components and niche medical-market applications. - Custom single-use and single-patient medical devices - Protective drapes for robotic surgery - Infection prevention and surgical disposables - Medical device and implant packaging - Orthopedic soft goods and implant components - Biopharma drug manufacturing components ## Customers UFP Technologies sells primarily to medical device manufacturers that outsource development and production of specialized disposable components. Its customer base includes large OEMs in minimally invasive surgery, orthopedics, infection prevention, and other medical end markets, where custom design and manufacturing speed matter. The company also serves biopharma-related customers for specialized manufacturing components. - **Medical device OEMs** (primary) — Buy custom-engineered single-use devices and components for integration into finished medical products. - **Minimally invasive surgery platforms** (primary) — Buy drapes, disposables, and protective components used in robotic and endoscopic procedures. - **Orthopedic manufacturers** (secondary) — Buy soft goods, packaging, and implant-related components for orthopedic applications. - **Infection prevention and wound care customers** (secondary) — Buy specialty materials and disposables designed to reduce contamination and improve patient care. - **Biopharma customers** (emerging) — Buy niche manufacturing components used in drug manufacturing and related processes. - Large medical device OEMs outsourcing custom component production - Minimally invasive surgery customers needing sterile disposable parts - Orthopedic customers buying soft goods, packaging, and implant components - Infection prevention and wound care customers needing specialty materials - Biopharma customers needing specialized manufacturing components ## Geography UFP Technologies is headquartered in the United States and manufactures goods in the U.S. and outside the U.S. for global medical customers. Its end markets are international, but the business is operationally sensitive to trade policy because tariffs can affect both imported materials and cross-border manufacturing flows. - Headquartered in the United States - Manufactures in the U.S. and in foreign countries - Sells to global medical device customers - Tariffs can affect imported materials and finished goods flows - Cross-border supply chains matter for cost and delivery timing ## Strategy The company’s strategy centers on organic growth in specialized medical niches and expansion through acquisitions. It competes by combining engineering know-how, specialty materials, and custom manufacturing to help customers speed time to market and improve product performance. - **Organic growth in medical niches** (medium-term) — Custom solutions and specialized materials support higher-value customer relationships. - **Acquisition-led expansion** (short-term) — Acquisitions broaden the product set and customer base in adjacent medical categories. - **Customer collaboration and direct sales** (medium-term) — Direct engineering and commercial engagement helps win custom programs and retain OEM accounts. - Grow in niche medical segments with custom-engineered solutions - Use acquisitions to add capabilities, customers, and scale - Deepen relationships with large medical OEMs through direct sales - Leverage specialty materials and design expertise to differentiate - Expand manufacturing capacity and operating efficiency ## Risks UFP Technologies depends on a concentrated set of large medical customers, so volume losses or pricing pressure from a few accounts can materially affect results. The business also faces supply-chain, tariff, and integration risks because it relies on specialty materials, international manufacturing, and acquisitions to support growth. - **Customer concentration** [high] — Two customers represented a very large share of net sales, so loss or slowdown at either account would be material. - **Tariff and trade policy exposure** [medium] — The company manufactures outside the U.S. and buys materials that can be affected by import tariffs and retaliatory trade actions. - **Acquisition integration risk** [medium] — Growth through acquisitions can create execution risk around systems, customers, and realized synergies. - **Supply chain and materials risk** [medium] — Custom medical products depend on specialized inputs and reliable supplier relationships. - **Regulatory and climate-related operating risk** [low] — Medical manufacturing is exposed to changing regulations, customer standards, and physical supply disruptions. - Customer concentration creates revenue risk if a major OEM reduces orders - Tariffs can raise input costs and disrupt cross-border supply chains - Acquisitions may not deliver expected synergies or integration benefits - Specialty material availability can affect production and delivery - Climate and regulatory changes can increase operating and compliance costs ## Accounting The most important accounting judgments relate to goodwill and intangible assets from acquisitions, which are tested for impairment and amortized over time. Investors should also watch deferred tax asset realization, debt covenant compliance, and how acquisition accounting affects reported earnings through amortization and purchase accounting adjustments. - **Goodwill and intangible assets** — Can cause non-cash charges and affect reported earnings - **Deferred tax assets** — Can change tax expense and net income - **Debt and covenant accounting** — Affects liquidity disclosure and going-concern risk assessment - **Acquisition accounting** — Affects amortization, goodwill, and post-deal comparability - Goodwill and intangible asset impairment risk from acquisition-heavy growth - Amortization of definite-lived intangibles reduces reported earnings - Deferred tax asset realizability depends on future taxable income - Debt covenants and borrowings affect liquidity and financial flexibility - Acquisition accounting can create purchase price allocation effects --- *Last updated: 2026-04-29T05:05:02.103263+00:00*